To view digital features for this article go to Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a class of incretin-based therapies for the treatment of type 2 diabetes (T2D), have been shown to be highly effective for both glycaemic control and weight loss, and are associated with a low risk of hypoglycaemia [1]
When cortisol is elevated, the body can enter fight, flight or freeze mode, shutting down non-essential functions like digestion
Side effects are usually minimal or non-existent
Poor sleep and chronic stress can lead to emotional eating, which could undermine your progress on GLP-1 medications
[DOI] [PMC free article] [PubMed] [Google Scholar] 65.Rakariyatham K., Wu X., Tang Z., Han Y., Wang Q., Xiao H
Their energy feels steadier